# US 2004/0019008 A1 · Compositions and processes using siRNA, amphipathic compounds and polycations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0019008 A1
- Document ID: US20040019008A1
- Status: Published application
- Kind: A1
- Application number: 10/621,760
- Filed: 2003-07-17
- Published: 2004-01-29
- Earliest claimed: 2002-05-28
- Inventors: David L. Lewis; James E. Hagstrom; Hans Herweijer; Aaron G. Loomis; Sean D. Monahan; Jon A. Wolff; Vladimir Trubetskoy
- Web page: https://patentgrep.com/patent/US20040019008A1

## CPC

- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- A61K 31/58: containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048})
- A61K 31/74: Synthetic polymeric materials
- C12N 15/88: using microencapsulation, e.g. using {amphiphile} liposome vesicle
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2320/32: Special delivery means, e.g. tissue-specific
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Described is a composition with low toxicity comprising an amphipathic compound and a polycation, useful for delivering siRNA to a cell. The composition may be used in the process of delivering a siRNA to an animal cell, or more particularly a mammal cell, in a multi-well format.

## Claims

### Claim 1

A deliverable composition comprising: an amphipathic compound, a polycation selected from the group consisting of polyvinylamine and polyallylamine, and an siRNA.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the amphipathic compound has the structure comprising:
6
wherein R1 and R2 are selected from the group consisting of a C6 to C24 alkane, C6-C24 alkene, cycloalkyl, sterol, steroid, substituted lipid, acyl segment of a fatty acid, hydrophobic hormone, and hydrophobic hormone analog.

### Claim 3 (depends on 2)

The composition of claim 2 wherein R1 and R2 of the amphipathic compound are the same.

### Claim 4 (depends on 2)

The composition of claim 2 wherein R1 and R2 of the amphipathic compound of are different.

### Claim 5

A process for delivering a siRNA to an animal cell comprising: associating the cell with a composition comprising an amphipathic compound, an effective amount of a polycation selected from the group consisting of polyvinylamine and polyallylamine, and a siRNA in solution.

### Claim 6 (depends on 6)

The process of claim 6 wherein the animal cell is in vivo.

### Claim 7 (depends on 6)

A process of claim 6 wherein the animal cell is in vitro.

### Claim 8 (depends on 6)

The process of claim 6 wherein the animal cell is ex vivo.

### Claim 9 (depends on 6)

The process of claim 6 wherein the animal cell is a mammalian cell.
